First Horizon Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
4,518
-2,424
| -35% | -$165K | 0.01% | 432 |
|
|
2025
Q1 | $482K | Sell |
6,942
-141
| -2% | -$11.6K | 0.01% | 344 |
|
|
2024
Q4 | $609K | Sell |
7,083
-155
| -2% | -$16.8K | 0.02% | 307 |
|
|
2024
Q3 | $862K | Buy |
7,238
+2,582
| +55% | +$344K | 0.02% | 268 |
|
|
2024
Q2 | $665K | Buy |
4,656
+1,334
| +40% | +$177K | 0.02% | 296 |
|
|
2024
Q1 | $427K | Sell |
3,322
-342
| -9% | -$40.7K | 0.01% | 356 |
|
|
2023
Q4 | $379K | Sell |
3,664
-271
| -7% | -$26.8K | 0.01% | 365 |
|
|
2023
Q3 | $358K | Buy |
3,935
+51
| +1% | +$4.49K | 0.01% | 362 |
|
|
2023
Q2 | $314K | Buy |
3,884
+4
| +0.1% | +$327 | 0.01% | 396 |
|
|
2023
Q1 | $309K | Sell |
3,880
-708
| -15% | -$50.2K | 0.01% | 391 |
|
|
2022
Q4 | $311K | Sell |
4,588
-408
| -8% | -$23.9K | 0.01% | 381 |
|
|
2022
Q3 | $248K | Sell |
4,996
-1,018
| -17% | -$54.5K | 0.01% | 400 |
|
|
2022
Q2 | $335K | Buy |
6,014
+5,124
| +576% | +$284K | 0.01% | 378 |
|
|
2022
Q1 | $49K | Sell |
890
-2,632
| -75% | -$135K | ﹤0.01% | 649 |
|
|
2021
Q4 | $197K | Sell |
3,522
-144
| -4% | -$7.8K | 0.01% | 497 |
|
|
2021
Q3 | $175K | Sell |
3,666
-222
| -6% | -$10.7K | 0.01% | 529 |
|
|
2021
Q2 | $161K | Sell |
3,888
-200
| -5% | -$7.75K | 0.01% | 434 |
|
|
2021
Q1 | $138K | Sell |
4,088
-172
| -4% | -$6.13K | 0.01% | 441 |
|
|
2020
Q4 | $148K | Sell |
4,260
-194
| -4% | -$6.71K | 0.01% | 358 |
|
|
2020
Q3 | $154K | Sell |
4,454
-566
| -11% | -$18.9K | 0.01% | 338 |
|
|
2020
Q2 | $164K | Sell |
5,020
-54
| -1% | -$1.72K | 0.01% | 327 |
|
|
2020
Q1 | $152K | Sell |
5,074
-236
| -4% | -$7.03K | 0.01% | 322 |
|
|
2019
Q4 | $152K | Sell |
5,310
-206
| -4% | -$5.7K | 0.01% | 371 |
|
|
2019
Q3 | $142K | Sell |
5,516
-3,818
| -41% | -$96.5K | 0.01% | 373 |
|
|
2019
Q2 | $238K | Sell |
9,334
-1,836
| -16% | -$45.4K | 0.02% | 313 |
|
|
2019
Q1 | $292K | Sell |
11,170
-1,400
| -11% | -$34.4K | 0.02% | 292 |
|
|
2018
Q4 | $288K | Buy |
12,570
+2,264
| +22% | +$50.3K | 0.03% | 281 |
|
|
2018
Q3 | $242K | Sell |
10,306
-3,928
| -28% | -$95.9K | 0.02% | 337 |
|
|
2018
Q2 | $327K | Buy |
14,234
+750
| +6% | +$17.8K | 0.03% | 300 |
|
|
2018
Q1 | $330K | Sell |
13,484
-820
| -6% | -$21.5K | 0.03% | 243 |
|
|
2017
Q4 | $391K | Sell |
14,304
-1,610
| -10% | -$40.9K | 0.04% | 233 |
|
|
2017
Q3 | $388K | Sell |
15,914
-362
| -2% | -$8.18K | 0.04% | 227 |
|
|
2017
Q2 | $361K | Sell |
16,276
-1,136
| -7% | -$22.9K | 0.04% | 233 |
|
|
2017
Q1 | $332K | Sell |
17,412
-4,206
| -19% | -$73.2K | 0.04% | 251 |
|
|
2016
Q4 | $438K | Hold |
21,618
| – | – | 0.06% | 221 |
|
|
2016
Q3 | $438K | Buy |
21,618
+17,314
| +402% | +$429K | 0.06% | 217 |
|
|
2016
Q2 | $115K | Sell |
4,304
-1,634
| -28% | -$44.8K | 0.02% | 367 |
|
|
2016
Q1 | $158K | Buy |
5,938
+1,012
| +21% | +$27.1K | 0.02% | 354 |
|
|
2015
Q4 | $142K | Sell |
4,926
-892
| -15% | -$24.7K | 0.03% | 312 |
|
|
2015
Q3 | $157K | Sell |
5,818
-314
| -5% | -$8.89K | 0.02% | 324 |
|
|
2015
Q2 | $167K | Sell |
6,132
-892
| -13% | -$25.1K | 0.02% | 336 |
|
|
2015
Q1 | $190K | Sell |
7,024
-2,774
| -28% | -$63.9K | 0.03% | 321 |
|
|
2014
Q4 | $208K | Sell |
9,798
-382
| -4% | -$8.53K | 0.03% | 305 |
|
|
2014
Q3 | $242K | Buy |
10,180
+470
| +5% | +$10.8K | 0.04% | 281 |
|
|
2014
Q2 | $220K | Buy |
9,710
+4,928
| +103% | +$109K | 0.03% | 313 |
|
|
2014
Q1 | $106K | Sell |
4,782
-11,038
| -70% | -$235K | 0.01% | 394 |
|
|
2013
Q4 | $74K | Buy |
15,820
+14,880
| +1,583% | +$259K | 0.01% | 423 |
|
|
2013
Q3 | $16K | Buy |
940
+40
| +4% | +$673 | ﹤0.01% | 720 |
|
|
2013
Q2 | $14K | Buy |
+900
| New | +$15K | 0.01% | 437 |
|
Other funds holding NVO
F
First Horizon Advisors's NVO Position: Q2 2025 in Review
First Horizon Advisors reduced its Novo Nordisk (NVO) stake by 35% in Q2 2025, selling an estimated $165K and leaving 4,518 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #432.
First Horizon Advisors first reported a position in NVO in Q2 2013 and has held it in 49 quarters since. The position peaked at $862K in Q3 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.
- First Horizon Advisors held 4,518 shares of Novo Nordisk worth $312K as of Q2 2025.
- First Horizon Advisors sold 2,424 Novo Nordisk shares in Q2 2025, an estimated $165K.
- Novo Nordisk made up 0.01% of First Horizon Advisors's portfolio in Q2 2025, its #432 holding.
- First Horizon Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Novo Nordisk position peaked at $862K in Q3 2024.
- 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.